HAN's Anchor Mission Communications Toolkit

Healthcare Anchor Network's (HAN) Anchor Mission Communications Toolkit

March 2, 2020
Mobilizing anchor institutions

Hospitals and health systems and other anchor institutions across the country are adopting an anchor mission to tackle the underlying economic and social determinants of community health outcomes and well being. But how can both the what and the why of this new transformative approach be effectively communicated, inside and outside anchor institutions?

The HAN Anchor Mission Communications Toolkit provides communications tips, tools and examples from Rush University Medical Center, along with other HAN members and higher education anchor institutions, to help with the work of communicating an anchor mission approach.

More related work

June 23, 2020
Default Image

Racial & Ethnic Economic Inequality and the COVID-19 Pandemic

by Thomas Hanna

The Democracy Collaborative prepared a report, created for the Healthcare Anchor Network, that looked at how racial and ethnic disparities in the economy are showing up in the COVID-19 pandemic and in the public policy response to the pandemic. The report also covers how the economic effects of the pandemic will likely impact racial and ethnic inequality.

read more
May 18, 2020
Digital infrastructure panel

Democratic digital infrastructure

by Thomas Hanna, Mathew Lawrence, Miriam Brett, Adrienne Buller

The global spread of Covid-19 has shone a bright spotlight on both the vital need for reliable high-speed internet and the inadequacies of the for-profit, corporate model in delivering it. This paper, the first of four modules on democratic public ownership in the United Kingdom and the US, explores

read more
An array of prescription medications on shelves

Medicine For All: The case for a public option in the pharmaceutical industry

by Dana Brown

Democratic, public ownership of pharmaceutical development, production, and distribution in the U.S. is necessary to combat the increasingly harmful impacts of Big Pharma which decades of regulation have failed to counteract.

read more